Shares of Gilead Sciences are attracting the attention of Wall Street analysts. Originally published at CNBC
Find More
Trending News
- Watch CNBC’s lookback at Charlie Munger’s life and relationship with Warren Buffett
- Charlie Munger’s sharp wit turned Berkshire meetings into uproarious affairs. Here’s a sample
- The investing world reacts to death of Berkshire legend Charlie Munger
- Charlie Munger in final interview describes how he and Buffett made Berkshire into what it is
- Fearless Fund grant program was already ‘at risk’ before lawsuit
- Aave’s GHO Stablecoin Nears Elusive Dollar Peg
- Polestar’s climate-tweeting bot isn’t actually a bot, for good reason
- LockBit claims cyberattack on India’s national aerospace lab
- The TechCrunch+ 2023 Holiday Gift Guide
- Saudi Arabia Wins Bid to Host World Expo 2030